Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study

NCT05602935 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms
Digestive System Neoplasms
Neoplasms
Digestive System Diseases
Stomach Diseases
Neoplasms by Site

Interventions

DRUG: Camrelizumab
DRUG: SOX
PROCEDURE: Surgery

Sponsor

The Second Affiliated Hospital of Fujian Medical University